In a remarkable achievement, scientists have succeeded in developing a new method to treat Parkinson’s disease. This method, called adaptive deep brain stimulation (aDBS), uses artificial intelligence to personalize treatment and improve patients’ quality of life.
In this method, an implantable device is placed in the patient’s brain, which uses artificial intelligence to analyze brain activities and adjust the level of electrical stimulation in real time. This allows the treatment to be precisely tailored to the needs of each patient and the symptoms of the disease to be controlled more effectively.
One of the advantages of aDBS compared to traditional methods is its higher effectiveness. Studies have shown that aDBS is much more effective in controlling the symptoms of Parkinson’s disease compared to traditional deep brain stimulation methods. Also, this treatment method is adjusted according to the needs of each patient and causes a significant improvement in the quality of life of patients. The implantable device automatically adjusts the level of stimulation based on the patient’s needs.
Despite all the benefits of aDBS, there are still challenges in accessing this treatment. Among these challenges, we can mention the need to train specialists and provide the necessary infrastructure. The development of aDBS treatment method is a big step towards improving the quality of life of Parkinson’s patients. With further advances in artificial intelligence, we can expect this treatment to improve in the future and help many patients.
RCO NEWS